Description

NSE notifies admission of privately placed commercial paper securities from multiple issuers to the debt market segment effective December 23, 2025.

Summary

NSE has admitted privately placed commercial paper (CP) securities from 10 issuers to the debt market segment effective December 23, 2025. All securities were allotted on December 22, 2025, with redemption dates ranging from March to June 2026. Total value exceeds Rs 35,000 crore across various corporate issuers.

Key Points

  • 10 commercial paper issuances from corporate entities admitted to NSE debt market
  • All securities allotted on December 22, 2025
  • Effective listing date: December 23, 2025
  • Face value: Rs 5,00,000 per security across all issuances
  • Redemption periods: 87-182 days (March-June 2026)
  • Issuers include: Alembic Pharmaceuticals, Minda Corporation, Barclays Investments & Loans India, Tata Capital, Biocon, Godrej Industries, IIFL Finance, CESC, Cholamandalam Investment and Finance, IIFL Capital Services
  • Largest issuance: Biocon Limited with 36,000 securities (Rs 18,000 crore)

Regulatory Changes

No regulatory changes. This is a routine listing notification under NSE Debt Market (Trading) Regulations 3.1.1.

Compliance Requirements

No new compliance requirements. Standard debt market listing obligations apply to the issuing companies.

Important Dates

  • Allotment Date: December 22, 2025 (all securities)
  • Listing Date: December 23, 2025
  • Redemption Dates:
    • March 10, 2026: IIFL Capital Services
    • March 19, 2026: Minda Corporation
    • March 20, 2026: Biocon, CESC
    • March 23, 2026: Alembic Pharmaceuticals, Barclays, Tata Capital, Godrej Industries, Cholamandalam
    • June 22, 2026: IIFL Finance

Impact Assessment

Minimal market impact. This is a standard administrative notification for debt securities listing. The commercial paper issuances represent routine short-term corporate funding activities in the debt market. Trading in these securities will be limited to institutional investors in the debt segment and does not affect equity markets or retail investors.

Impact Justification

Routine listing notification for privately placed commercial paper securities with no market-wide regulatory changes or trading implications